Gland Pharma plunges to 52-week low as Q4 net profit slumps 72.5%, revenue drops 29%
The drugmaker's net profit for the quarter plummeted to Rs 78.6 crore due to high base on account of COVID sales and a shutdown of production line in the Pashamylaram Penems facility for line upgradation.